New patent expiration for APGDI drug MYRBETRIQ
Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting…
Source
Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting…
Source
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. It is available from one supplier. There are ten…
Source
Get new actionable insights and updates from BiotechBlog